CFDB - Cystic Fibrosis DataBase

  1. Home
  2. Database
Search (?)
at least one term
all terms
Advanced search
ongoing trials trial from www.clinicaltrials.gov

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis - - RECRUITING

  • Year: 2024
  • Date: 2024
  • Author:
Source

https://clinicaltrials.gov/study/NCT06429176

Participants

adult patients with cystic fibrosis (CF). -

Interventions

multiple doses of the study drug, SPL84drug SPL84 or a placebo by inhalation every week for 9 weeks months

Outcome measures

Safety and effectiveness. Patients will Visit the clinic approximately 14 times over 17.5 weeks for checkups and tests". Number of subjects with at least one treatment-related adverse event (AE) or serious adverse event (SAEs), Incidence, nature, and severity of AEs and SAEs, Day 1 through Day 87

Keywords: SPL84; Respiratory System Agents; pharmacological_intervention;